Navigation Links
Risk factors help predict outcomes for children with rare heart condition
Date:9/3/2013

A long-term study of children with a complex heart condition called hypertrophic cardiomyopathy (HCM) found that the risk of death or need for immediate listing for heart transplantation was greatest for those who developed this disease as infants with congestive heart failure and for children who also had selective inborn errors of metabolism, a group of rare genetic disorders in which one or more of the body's key metabolic processes are disrupted.

The findings will be published online Tuesday in The Lancet to coincide with a presentation at the European Society of Cardiology Congress 2013 meeting in Amsterdam. The National Heart, Lung, and Blood Institute (NHLBI) and the Children's Cardiomyopathy Foundation supported this research.

Hypertrophic cardiomyopathy, a type of pediatric cardiomyopathy (diseases of the heart muscle) with varied causes and outcomes, is characterized by increased thickness (hypertrophy) of the heart wall.

HCM is rare, with fewer than one out of 100,000 children (ages birth to 18 years old) diagnosed annually in the United States. The condition is more frequently diagnosed in infants (under the age of one year), with 2 to 3 out of every 100,000 identified each year.

Researchers from the University of Miami Miller School of Medicine, along with colleagues from other institutions, sought to better understand how risk factors at the time of HCM diagnosis are predictors of death or the need to be added to a heart transplantation waiting list. They spent 19 years amassing data on more than 1,000 affected children at 98 pediatric cardiology centers in the U.S. and Canada through the NHLBI-funded Pediatric Cardiomyopathy Registry.

Researchers found that children with HCM caused by inborn errors of metabolism had the lowest rate of transplant-free survival within two years after diagnosis (43 percent). At two years after diagnosis, the rate of transplant-free survival was 55 percent for children with a mixed version of the disease that included thickening of the heart walls and enlargement and weakening of the heart and 62 percent for those with a restrictive form of the disease characterized by both a thickening and hardening of the heart walls. Children diagnosed after age one year with hypertrophic cardiomyopathy of unknown cause had the most favorable outcome, a 97 percent rate of transplant-free survival.

Infants and children who had two or more of the following risk factors at HCM diagnosis (depending on the cause of HCM) lower weight or body size, female gender, diagnosis during infancy, congestive heart failure, and abnormal heart function had an increased risk of poor outcomes (death or need for immediate heart transplantation).

These findings are expected to assist clinicians in identifying which children are likely to have the worst outcomes (death or need for immediate heart transplantation) within two years of diagnosis, thereby enabling medical teams, genetic counselors, and family planners to jointly and quickly determine the best treatment approach.


'/>"/>

Contact: NHLBI Communications Office
nhlbi_news@nhlbi.nih.gov
301-496-4236
NIH/National Heart, Lung and Blood Institute
Source:Eurekalert

Related biology news :

1. Environmental factors in Tiny Tims near fatal illness
2. Soy-based S-equol supplement reduces metabolic syndrome risk factors
3. Impaired recovery of Atlantic cod -- forage fish or other factors?
4. Longer sleep times may counteract genetic factors related to weight gain
5. Time, place and how wood is used are factors in carbon emissions from deforestation
6. Some factors that impact islet transplantation explored in Cell Transplantation papers
7. Some factors that impact islet transplantation explored in Cell Transplantation papers
8. True blood: SLU scientist investigates clotting factors
9. Johns Hopkins researchers link 2 biological risk factors for schizophrenia
10. Forest killer plant study explores rapid environmental change factors
11. Social factors trump genetic forces in forging friendships, CU-led study finds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2016)... and DE SOTO, Kansas ... U.S.-based Stroke Detection Plus® to offer Oncimmune,s Early ... assessment and early detection of lung cancer ... employers, unions and individuals. --> Early CDT®-Lung ... and individuals. --> Oncimmune, a leader in ...
(Date:3/2/2016)... 2016 http://www.researchandmarkets.com/research/cmt3hk/global_biometrics ) ... "Global Biometrics as a Service Market 2016-2020" ... --> http://www.researchandmarkets.com/research/cmt3hk/global_biometrics ) has announced the ... a Service Market 2016-2020" report to ... and Markets ( http://www.researchandmarkets.com/research/cmt3hk/global_biometrics ) has announced ...
(Date:3/1/2016)... -- (RSAC Booth #3041) – True fraud costs business $9 ... lost to false positives, where good customers are pushed ... the RSA Conference 2016, NuData Security is calling for a ... devaluing the data fraudsters have in abundance in favor ... --> --> Cheap and readily available ...
Breaking Biology News(10 mins):
(Date:4/26/2016)... , ... April 27, 2016 , ... ... Lewis Roca Rothgerber Christie LLP as an associate in the firm’s Intellectual Property ... international electrical, mechanical and electromechanical patent applications. He has an electrical engineering and ...
(Date:4/26/2016)... ... April 26, 2016 , ... Heidelberg Instruments, a ... technology innovation for its Volume Pattern Generator (VPG) line of lithography systems. The ... photomasks as well as a solution for mid volume direct write lithography applications. ...
(Date:4/26/2016)... ... April 26, 2016 , ... BioFactura, Inc ., a ... round of financing. Healthy investor interest drove significant oversubscription of the original $1.5M ... known as biosimilars, to the advanced preclinical stages. , Chief Executive Officer and President, ...
(Date:4/26/2016)... ... , ... uBiome, the leading microbial genomics company, welcomes Neil Grimmer, Co-founder and ... to co-founding Plum in 2007, Neil Grimmer was Vice President of Strategy and Innovation ... designer of ideas, products, and brands, Grimmer has been at the forefront of launching ...
Breaking Biology Technology: